311 related articles for article (PubMed ID: 28423619)
1. CDCA2 promotes lung adenocarcinoma cell proliferation and predicts poor survival in lung adenocarcinoma patients.
Shi R; Zhang C; Wu Y; Wang X; Sun Q; Sun J; Xia W; Dong G; Wang A; Jiang F; Xu L
Oncotarget; 2017 Mar; 8(12):19768-19779. PubMed ID: 28423619
[TBL] [Abstract][Full Text] [Related]
2. Upregulation of CDCA5 promotes gastric cancer malignant progression via influencing cyclin E1.
Zhang Z; Shen M; Zhou G
Biochem Biophys Res Commun; 2018 Feb; 496(2):482-489. PubMed ID: 29326043
[TBL] [Abstract][Full Text] [Related]
3. ZYG11A serves as an oncogene in non-small cell lung cancer and influences CCNE1 expression.
Wang X; Sun Q; Chen C; Yin R; Huang X; Wang X; Shi R; Xu L; Ren B
Oncotarget; 2016 Feb; 7(7):8029-42. PubMed ID: 26771237
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.
Uchida F; Uzawa K; Kasamatsu A; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Bukawa H; Tanzawa H
PLoS One; 2013; 8(2):e56381. PubMed ID: 23418564
[TBL] [Abstract][Full Text] [Related]
5. CDCA2 promotes the proliferation of colorectal cancer cells by activating the AKT/CCND1 pathway in vitro and in vivo.
Feng Y; Qian W; Zhang Y; Peng W; Li J; Gu Q; Ji D; Zhang Z; Wang Q; Zhang D; Sun Y
BMC Cancer; 2019 Jun; 19(1):576. PubMed ID: 31196027
[TBL] [Abstract][Full Text] [Related]
6. WDR62 overexpression is associated with a poor prognosis in patients with lung adenocarcinoma.
Shinmura K; Kato H; Kawanishi Y; Igarashi H; Inoue Y; Yoshimura K; Nakamura S; Fujita H; Funai K; Tanahashi M; Niwa H; Ogawa H; Sugimura H
Mol Carcinog; 2017 Aug; 56(8):1984-1991. PubMed ID: 28277612
[TBL] [Abstract][Full Text] [Related]
7. DDA1, a novel oncogene, promotes lung cancer progression through regulation of cell cycle.
Cheng L; Yang Q; Li C; Dai L; Yang Y; Wang Q; Ding Y; Zhang J; Liu L; Zhang S; Fan P; Hu X; Xiang R; Yu D; Wei Y; Deng H
J Cell Mol Med; 2017 Aug; 21(8):1532-1544. PubMed ID: 28211159
[TBL] [Abstract][Full Text] [Related]
8. Cell division cycle associated 2 (CDCA2) upregulation promotes the progression of hepatocellular carcinoma in a p53-dependant manner.
Wang J; Liu X; Chu H; Chen J
PeerJ; 2022; 10():e13535. PubMed ID: 35694386
[TBL] [Abstract][Full Text] [Related]
9. MARCH9 Suppresses Lung Adenocarcinoma Progression by Downregulating ICAM-1.
Shen QM; Wang HY; Xu S
Cell Physiol Biochem; 2018; 50(1):92-107. PubMed ID: 30278450
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Impact of Cell Division Cycle Associated 2 Expression on Pancreatic Ductal Adenocarcinoma.
Wang MY; Niu ZY; Gao XG; Zhou L; Liao Q; Zhao YP
Chin Med Sci J; 2016 Sep; 31(3):149-154. PubMed ID: 27733221
[TBL] [Abstract][Full Text] [Related]
11. PHD-finger domain protein 5A functions as a novel oncoprotein in lung adenocarcinoma.
Yang Y; Zhu J; Zhang T; Liu J; Li Y; Zhu Y; Xu L; Wang R; Su F; Ou Y; Wu Q
J Exp Clin Cancer Res; 2018 Mar; 37(1):65. PubMed ID: 29566713
[TBL] [Abstract][Full Text] [Related]
12. TMEM45B, up-regulated in human lung cancer, enhances tumorigenicity of lung cancer cells.
Hu R; Hu F; Xie X; Wang L; Li G; Qiao T; Wang M; Xiao H
Tumour Biol; 2016 Sep; 37(9):12181-12191. PubMed ID: 27225290
[TBL] [Abstract][Full Text] [Related]
13. Increased KIF15 Expression Predicts a Poor Prognosis in Patients with Lung Adenocarcinoma.
Qiao Y; Chen J; Ma C; Liu Y; Li P; Wang Y; Hou L; Liu Z
Cell Physiol Biochem; 2018; 51(1):1-10. PubMed ID: 30439711
[TBL] [Abstract][Full Text] [Related]
14. CDCA2 promotes melanoma progression by inhibiting ubiquitin-mediated degradation of Aurora kinase A.
Sun W; Jin Y; Wei C; Xu Y; Liu W; Zhong J; Zou Z; Lin X; Xiang Y; Chen Y
Eur J Cancer; 2023 Jul; 188():49-63. PubMed ID: 37196484
[TBL] [Abstract][Full Text] [Related]
15. MAP3K3 expression in tumor cells and tumor-infiltrating lymphocytes is correlated with favorable patient survival in lung cancer.
He Y; Wang L; Liu W; Zhong J; Bai S; Wang Z; Thomas DG; Lin J; Reddy RM; Ramnath N; Carrott PW; Lynch WR; Orringer MB; Chang AC; Beer DG; Chen G
Sci Rep; 2015 Jun; 5():11471. PubMed ID: 26088427
[TBL] [Abstract][Full Text] [Related]
16. Keratin 17 Promotes Lung Adenocarcinoma Progression by Enhancing Cell Proliferation and Invasion.
Liu J; Liu L; Cao L; Wen Q
Med Sci Monit; 2018 Jul; 24():4782-4790. PubMed ID: 29991674
[TBL] [Abstract][Full Text] [Related]
17. CCNE1 Promotes Progression and is Associated with Poor Prognosis in Lung Adenocarcinoma.
Ma G; Yang L; Dong J; Zhang L
Curr Pharm Biotechnol; 2022; 23(9):1168-1178. PubMed ID: 34792009
[TBL] [Abstract][Full Text] [Related]
18. Role of HOXB7 in regulation of progression and metastasis of human lung adenocarcinoma.
Yuan W; Zhang X; Xu Y; Li S; Hu Y; Wu S
Mol Carcinog; 2014 Jan; 53(1):49-57. PubMed ID: 22911672
[TBL] [Abstract][Full Text] [Related]
19. CDCA2 Promotes HCC Cells Development via AKT-mTOR Pathway.
Li K; Fan T; Shi Z; Jiang H
Anal Cell Pathol (Amst); 2022; 2022():9912254. PubMed ID: 36588796
[TBL] [Abstract][Full Text] [Related]
20. PRC1 contributes to tumorigenesis of lung adenocarcinoma in association with the Wnt/β-catenin signaling pathway.
Zhan P; Zhang B; Xi GM; Wu Y; Liu HB; Liu YF; Xu WJ; Zhu QQ; Cai F; Zhou ZJ; Miu YY; Wang XX; Jin JJ; Li Q; Qian LP; Lv TF; Song Y
Mol Cancer; 2017 Jun; 16(1):108. PubMed ID: 28646916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
